Prevention of thalassemia in India

Indian Pediatrics

Volumn 44, Issue 9, 2007, Pages 647-

  Thacker, Naveen ^a  

^a Deep Children Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE;

AUTOSOMAL RECESSIVE DISORDER; B THALASSEMIA GENE; BLOOD TRANSFUSION; CHELATION THERAPY; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; ENDOCRINE DISEASE; GENE; GENETIC COUNSELING; HEART DISEASE; HEPATITIS B; HEPATITIS C; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; OSTEOPOROSIS; PREVALENCE; SCREENING; STEM CELL TRANSPLANTATION; THALASSEMIA;

ADOLESCENT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INDIA; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; RISK ASSESSMENT;

EID: 34948892889     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Weatherall DJ, Clegg JB. The Thalassemia Syndromes. 4th ed. Oxford: Blackwell Scientific Publications; 2001.
2. Yaish HM. Thalassemia. http://www.emedicine.com/PED/topic2229.htm Accessed 6th August 2007.
3. Verma IC, Choudhry VP, Jain PK. Prevention of thalassemia: A necessity in India. Indian J Pediatr 1992; 59: 649-654.
4. Manglani M, Lokeshwar MR, Vani VG, Bhatia N, Mhaskar V. 'NESTROFT' - an effective screening test for b-Thalassemia trait. Indian Pediatr. 1997; 34: 703-708.
5. Ghotbi N, Tsukatani T. An economic review of the national screening policy to prevent thalassemia major in Iran. From: www.kier.kyoto-u.ac.jp/DP/ DP562. Accessed 6th August 2007.
6. Ostrowsky JT, Lippman A, Scriver CR. Cost-benefit analysis of a thalassemia disease prevention program. Am J Public Health 1985; 75:732-736.
7. World Health Organization: Human Genetics Programme. Division of Communicable Diseases. Community control of hereditary anaemias: memorandum for a WHO meeting. Bull WHO 1983; 61:63-80.